dan 2163 has been researched along with clozapine in 112 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (3.57) | 18.2507 |
| 2000's | 56 (50.00) | 29.6817 |
| 2010's | 43 (38.39) | 24.3611 |
| 2020's | 9 (8.04) | 2.80 |
| Authors | Studies |
|---|---|
| Andrieux, M; Besançon, R; Giros, B; Martres, MP; Pilon, C; Schwartz, JC; Sokoloff, P | 1 |
| Bouthenet, ML; Giros, B; Martres, MP; Schwartz, JC; Sokoloff, P | 1 |
| Coolen, HK; Glennon, JC; Kruse, CG; Lange, JH; Reinders, JH; Tolboom, JT | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR | 1 |
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
| Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR | 1 |
| Attar-Levy, D; Martinot, JL; Monnet, F; Paillère-Martinot, ML; Recassens, C; Trichard, C | 1 |
| Bayle, FJ; Ghaoui, S; Olie, JP | 1 |
| Naber, D | 1 |
| Möller, HJ | 1 |
| McAskill, R; Taylor, DM | 1 |
| Bebbington, P; Freemantle, N; Geddes, J; Harrison, P | 1 |
| Braus, DF; Jatzko, A; Ries, S; Schreiner, A | 1 |
| Kapur, S; Remington, G | 2 |
| Agelink, MW; Klieser, E; Linka, T; Lukas, K; Majewski, T; Ullrich, H; Wurthmann, C | 1 |
| Hilger, E; Kasper, S | 1 |
| Bartholini, F; Casu, MA; Gessa, GL; Marchese, G; Pani, L; Ruiu, S; Saba, P | 1 |
| Bayle, FJ; Chereau, I; Lancon, C; Llorca, PM | 1 |
| Bottlender, R; Dobmeier, P; Hofschuster, E; Jäger, M; Möller, HJ | 1 |
| Goudie, AJ; Smith, JA | 1 |
| Castle, DJ; Lambert, TJ | 1 |
| Abou El Ela, A; Galla, HJ; Härtter, S; Hiemke, C; Hüwel, S; Langguth, P; Lohmann, T | 1 |
| Henn, FA; Knopf, U; Thome, J; Zink, M | 1 |
| Bitter, I | 1 |
| Agelink, MW; Ak, I; Kavuk, I | 1 |
| Freudenreich, O; Goff, D; Stahl, S | 1 |
| Beer, MD; Cobb, AM; Kerwin, R; Launer, M; Matthiasson, P; Munro, J; Osborne, S; Purcell, S; Travis, M | 1 |
| Bryois, Ch; Sahli, Ch | 1 |
| Lawrie, S; McIntosh, A; Nadeem, Z | 2 |
| Cowan, C; George, S | 1 |
| Croissant, B; Hermann, D; Olbrich, R | 1 |
| Agelink, MW; Kämpf, P; Naber, D | 1 |
| Cook, B; Hoogenboom, G | 1 |
| Lawrie, S; McIntosh, A | 1 |
| Berk, M; Bourin, M; Dodd, S; Ivanovski, B; Lagopoulos, J; Malhi, GS; Mitchell, PB | 1 |
| Bergemann, N; Frick, A; Kopitz, J; Kress, KR | 1 |
| Brown, D; Fraser, K; Martin, M; Taylor, M; Turner, M; Watt, L | 1 |
| Frecska, E | 1 |
| Knecht, G; Naber, D; Veismann, S; Wolf, K | 1 |
| Kreinin, A; Novitski, D; Weizman, A | 1 |
| Baumgartner, S; Ebenbichler, C; Edlinger, M; Fleischhacker, WW; Hofer, A; Hummer, M; Kemmler, G; Lechleitner, M; Rettenbacher, MA | 1 |
| Baumgartner, S; Ebenbichler, C; Edlinger, M; Hofer, A; Hummer, M; Kemmler, G; Lechleitner, M; Rettenbacher, MA; Wolfgang Fleischhacker, W | 1 |
| Alonso, J; Haro, JM; Lépine, JP; Novick, D; Ratcliffe, M; Suarez, D | 1 |
| Limosin, F | 1 |
| Benitez, J; Daskalakis, ZJ; Egan, GF; Fitzgerald, PB; Jackson, G; Kulkarni, J; Sritharan, A | 1 |
| Bret, MC; Bret, P; Fourier-Réglat, A; Pariente, A | 1 |
| Cazali, J; Dervaux, A | 1 |
| Assion, HJ; Basilowski, M; Juckel, G; Lemanski, S; Reinbold, H | 1 |
| Lang, UE; Malte Tugtekin, S; Matschke, K; Schmeisser, A; von Golitschek, R; Willbring, M | 1 |
| Lawrie, SM; Shajahan, P; Taylor, M | 1 |
| Agai Csongor, E; Domány, G; Elekes, O; Gémesi, LI; Gyertyán, I; Kapás, M; Kedves, R; Kiss, B; Laszy, J; Pásztor, G; Sághy, K; Szombathelyi, Z; Zájer-Balázs, M | 1 |
| Barlow, KB; Kapur, S; Natesan, S; Nobrega, JN; Reckless, GE | 1 |
| Endo, S; Hamamura, T; Ishihara, T; Kuroda, S; Miyata, S; Taoka, H; Toma, K | 1 |
| Akyildiz, U; Balci, V; Sevincok, L | 1 |
| Kumar, R; Sachdev, PS | 1 |
| Ayesa, R; Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Pérez-Iglesias, R; Ramirez-Bonilla, M; Rodríguez-Sánchez, JM; Vázquez-Barquero, JL | 1 |
| Praharaj, SK; Sarkar, S; Sinha, VK | 1 |
| Barbui, C; Boso, M; Cipriani, A | 1 |
| Bhoopathi, PS; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schwarz, S | 1 |
| Duggan, L; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Chen, CC; Chen, YY; Hung, GC | 1 |
| Aggarwal, A; Sharma, DD | 1 |
| Davis, JM; Hunger, H; Kissling, W; Komossa, K; Leucht, S; Lobos, CA; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Bergman, J; Kreinin, A; Lerner, V; Libov, I; Miodownik, C; Shestakova, D; Sokolik, S | 1 |
| Eberle, MC; Fallgatter, AJ; Plewnia, C; Wasserka, B; Wildgruber, D | 1 |
| Claes, S; De Hert, M; Martens, GJ; Moons, T; Peuskens, J; Van Loo, KM; Van Schijndel, JE; van Winkel, R | 1 |
| Hunger, H; Kissling, W; Komossa, K; Leucht, S; Rummel-Kluge, C; Schmid, F; Schwarz, S | 1 |
| Englisch, S; Esslinger, C; Meyer-Lindenberg, A; Rausch, F; Schirmbeck, F; Zink, M | 1 |
| Ekström, J; Godoy, T; Riva, A | 2 |
| Chiu, HW; Huang, HT; Ku, YC; Li, TC | 1 |
| Body, S; Bradshaw, CM; de Bruin, N; den Boon, FS; Hampson, CL; Szabadi, E | 1 |
| Chang, YT; Chen, CC; Chen, WJ; Kuo, CJ; Lee, WC; Liao, YT; Shau, WY; Tsai, SY; Yang, SY | 1 |
| Bowskill, SV; Flanagan, RJ; Handley, SA; Patel, MX | 1 |
| Blagojević, D; Lečić-Toševski, D; Miljević, Č; Niketić, V; Nikolić, M; Nikolić-Kokić, A; Spasić, MB | 1 |
| Couchman, L; Fisher, DS; Flanagan, RJ; Handley, SA; Morgan, PE; Partridge, SJ | 1 |
| Fisher, DS; Flanagan, RJ; Handley, SA; Partridge, SJ | 1 |
| Tufan, AE; Yalug, I | 1 |
| Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L | 1 |
| Basu, A; Brooman-White, RS; Das, M; Gupta, N; Hotham, JE; Humphreys, SA; Larkin, F; Ross, CC; Simpson, PJ | 1 |
| Eifler, S; Englisch, S; Esslinger, C; Kirsch, P; Meyer-Lindenberg, A; Mier, D; Rausch, F; Schirmbeck, F; Zink, M | 1 |
| Bianchini, O; Porcelli, S; Serretti, A | 1 |
| Joyce, DW; Mateos Fernandez, MJ; Sarkar, SN; Shergill, SS; Tracy, DK | 1 |
| Bonnet, U; Gespers, H; Grabbe, D; Jahn, J; Kuhlmann, R; Montag, M; Ronge, R; Taazimi, B | 1 |
| Hema, T; Maran, S; Subhashini, G | 1 |
| Antczak, A; Górski, P; Karbownik, MS; Kowalczyk, E; Pietras, T; Szemraj, J; Wieteska, Ł | 1 |
| Bas, A; Bas, TO; Duran, A; Emul, M; Gultekin, G; Incir, S | 1 |
| Beyer, C; Fisher, DS; Flanagan, RJ; Seedat, S; van Schalkwyk, G | 1 |
| Barber, S; Cipriani, A; Corsi, M; Olotu, U | 1 |
| Amos, T; Bagalkote, H; Barnes, TR; Davies, L; Fitzgerald, Z; Fridrich, P; Haddad, PM; Husni, M; Iqbal, K; Keown, P; Kumar, R; Leeson, VC; Marston, L; Osborn, D; Paton, C; Singh, V; Whittaker, W; Zafar, R | 1 |
| Zipursky, RB | 1 |
| Arango, C; Dazzan, P; Díaz-Caneja, CM; Drake, R; Eijkemans, MJC; Fleischhacker, WW; Galderisi, S; Glenthøj, B; Heres, S; Kahn, RS; Kapur, S; Leboyer, M; Leucht, S; Lewis, SW; McGuire, P; Rujescu, D; Sommer, IE; Weiser, M; Winter van Rossum, I | 1 |
| Kahn, RS; Sommer, IE | 1 |
| Allan, S; Bradstreet, S; Gumley, A; Heriot-Maitland, C | 1 |
| Davis, JM; Leucht, S; Smith, RC | 1 |
| De Oliveira, EO; Donahue, TJ; Hillhouse, TM; Porter, JH; Webster, KA | 1 |
| Kraats, GV; Luykx, JJ; van Ojen, R | 1 |
| Jiménez-Gonzalo, F; Perea-Pérez, R; Plasencia-García de Diego, B; Ruiz-Doblado, S | 1 |
| Claro, A; Corte-Real, F; Franco, J; Monteiro, C; Mustra, C; Proença, P | 1 |
| Byeon, SJ; Chung, SJ; Oh, S | 1 |
| Osman, E; Yıldız, M | 1 |
| Qu, K; Shen, Y; Tian, L; Zhou, Q; Zhou, Z | 1 |
| Amad, A; Cuvelier, E; Décaudin, B; Fovet, T; Gressier, B; Simon, N | 1 |
| Hu, QY; Huang, Y; Jin, Y; Li, ZZ; Liu, MJ; Liu, ZJ; Lv, QY; Shi, DH; Tan, HY; Wu, FC; Yang, JY; Yi, ZH; Zhao, L; Zhu, MH; Zhu, N | 1 |
| Barone, A; Ciccarelli, M; de Bartolomeis, A; Fornaro, M; Iasevoli, F; Vellucci, L | 1 |
28 review(s) available for dan 2163 and clozapine
| Article | Year |
|---|---|
[New antipsychotic agents].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles | 1999 |
[New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Double-Blind Method; Dyskinesia, Drug-Induced; Humans; Imidazoles; Indoles; Neurotransmitter Agents; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles | 2000 |
Atypical antipsychotics and weight gain--a systematic review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles; Weight Gain | 2000 |
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Costs; Humans; Imidazoles; Indoles; Olanzapine; Pirenzepine; Quetiapine Fumarate; Regression Analysis; Risperidone; Schizophrenia; Sulpiride | 2000 |
Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dibenzothiepins; Dopamine Antagonists; Drug Monitoring; Haloperidol; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Receptors, Dopamine D4; Risperidone; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Sulpiride; Thiazoles; Treatment Outcome | 2001 |
[Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Topics: Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Dibenzothiepins; Haloperidol; Humans; Imidazoles; Indoles; Multicenter Studies as Topic; Olanzapine; Piperazines; Pirenzepine; Placebos; Quetiapine Fumarate; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride; Thiazoles | 2000 |
Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Models, Neurological; Olanzapine; Pirenzepine; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Schizophrenia; Sulpiride | 2001 |
Tardive dyskinesias and antipsychotics: a review.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Humans; Olanzapine; Pirenzepine; Prevalence; Psychotic Disorders; Risperidone; Sulpiride | 2002 |
Pharmacological approaches to the management of schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Pirenzepine; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride | 2003 |
Combination of clozapine and amisulpride in treatment-resistant schizophrenia--case reports and review of the literature.
Topics: Adult; Amisulpride; Antipsychotic Agents; Body Weight; Clozapine; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2004 |
[Current pharmacotherapy of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Risperidone; Schizophrenia; Serotonin Antagonists; Sulpiride; Thiazoles | 2004 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Cognitive Behavioral Therapy; Dibenzothiepins; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2003 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Haloperidol; Humans; Olanzapine; Patient Compliance; Perazine; Pimozide; Risperidone; Schizophrenia; Sulpiride | 2004 |
A typical mood stabilizers: a "typical role for atypical antipsychotics.
Topics: Affect; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Secondary Prevention; Sulpiride; Thiazoles | 2005 |
[From cradle to grave? Expectations from atypical antipsychotics].
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Sulpiride | 2005 |
Schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Chlorpromazine; Clozapine; Cognitive Behavioral Therapy; Dibenzothiepins; Family Therapy; Haloperidol; Humans; Patient Compliance; Risperidone; Schizophrenia; Secondary Prevention; Sulpiride; Thioridazine | 2005 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cognition Disorders; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2006 |
Akathisia and second-generation antipsychotic drugs.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles | 2009 |
Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Ziprasidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2009 |
Olanzapine versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2010 |
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Blood Glucose; Cholesterol; Clinical Trials as Topic; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2010 |
Risperidone versus other atypical antipsychotics for schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles | 2011 |
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Clozapine; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Piperazines; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Weight Gain | 2017 |
Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
Topics: Amisulpride; Antidepressive Agents; Antipsychotic Agents; Clozapine; Depression; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2019 |
[Treatment options for drug-induced sialorrhea: Prescribing guidelines].
Topics: Amisulpride; Antipsychotic Agents; Cholinergic Antagonists; Clozapine; Female; Humans; Male; Quality of Life; Scopolamine; Sialorrhea | 2022 |
Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Schizophrenia; Schizophrenia, Treatment-Resistant | 2022 |
13 trial(s) available for dan 2163 and clozapine
| Article | Year |
|---|---|
Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine.
Topics: Adult; Amisulpride; Antipsychotic Agents; Autonomic Nervous System; Benzodiazepines; Clozapine; Electrocardiography; Female; Heart; Heart Rate; Humans; Imidazoles; Indoles; Male; Middle Aged; Olanzapine; Pirenzepine; Prospective Studies; Sulpiride | 2001 |
Clozapine with amisulpride for refractory schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Drug Therapy, Combination; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2004 |
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine.
Topics: Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Diagnostic and Statistical Manual of Mental Disorders; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Schizophrenia; Sulpiride | 2004 |
Amisulpride has no effect on plasma clozapine concentrations.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Combinations; Drug Interactions; Female; Half-Life; Humans; Male; Middle Aged; Psychotic Disorders; Spectrophotometry, Ultraviolet; Sulpiride | 2005 |
Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Placebos; Schizophrenia; Sialorrhea; Sulpiride | 2006 |
Early changes of plasma lipids during treatment with atypical antipsychotics.
Topics: Adolescent; Adult; Aged; Amisulpride; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Cholesterol; Clozapine; Humans; Lipids; Middle Aged; Olanzapine; Piperazines; Prospective Studies; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Triglycerides | 2006 |
A preliminary fMRI study of the effects on cortical activation of the treatment of refractory auditory hallucinations with rTMS.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Combined Modality Therapy; Female; Functional Laterality; Hallucinations; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parietal Lobe; Reaction Time; Schizophrenia; Sulpiride; Temporal Lobe; Transcranial Magnetic Stimulation; Treatment Outcome | 2007 |
Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Brief Psychiatric Rating Scale; Clozapine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Pilot Projects; Schizophrenia; Sulpiride | 2008 |
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Prospective Studies; Psychotic Disorders; Risperidone; Severity of Illness Index; Sulpiride; Thiazoles | 2009 |
Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Clozapine; Cross-Over Studies; Female; Humans; Male; Middle Aged; Moclobemide; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Sialorrhea; Sulpiride | 2011 |
Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Psychiatric Status Rating Scales; Quality-Adjusted Life Years; Schizophrenia; Sulpiride; Technology Assessment, Biomedical; Treatment Outcome | 2017 |
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Clozapine; Europe; Female; Humans; Male; Olanzapine; Schizophrenia; Treatment Outcome; Young Adult | 2018 |
Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Cognition; Humans; Schizophrenia; Schizophrenia, Treatment-Resistant; Sulpiride | 2022 |
71 other study(ies) available for dan 2163 and clozapine
| Article | Year |
|---|---|
Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor.
Topics: Animals; Chlorides; CHO Cells; Cricetinae; Dopamine; Dopamine Agents; Dopamine Antagonists; Guanylyl Imidodiphosphate; Humans; Lithium; Lithium Chloride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Sodium Chloride; Sulpiride; Transfection | 1992 |
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
Topics: Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line; Cloning, Molecular; Cricetinae; DNA; DNA Restriction Enzymes; Dopamine; Guanylyl Imidodiphosphate; Molecular Sequence Data; Nucleic Acid Hybridization; Polymerase Chain Reaction; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Sequence Homology, Nucleic Acid; Tissue Distribution | 1990 |
Principal component analysis differentiates the receptor binding profiles of three antipsychotic drug candidates from current antipsychotic drugs.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzoxazines; Biogenic Monoamines; Humans; Hyperprolactinemia; Indoles; Metabolic Diseases; Phthalimides; Piperazines; Principal Component Analysis; Pyridines; Radioligand Assay; Receptors, Biogenic Amine; Weight Gain | 2007 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Highly predictive and interpretable models for PAMPA permeability.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine | 2017 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States | 2020 |
Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients.
Topics: Adolescent; Adult; Amisulpride; Animals; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorine Radioisotopes; Humans; Male; Pyrimidinones; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Schizophrenia; Sulpiride; Tomography, Emission-Computed | 1998 |
[Atypical antipsychotics].
Topics: Acute Disease; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cost-Benefit Analysis; Dibenzothiazepines; Dibenzothiepins; Dyskinesia, Drug-Induced; Germany; Humans; Neurotransmitter Agents; Olanzapine; Patient Compliance; Pirenzepine; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Sulpiride | 2000 |
[Acute tongue and pharyngeal spasms during changeover from clozapine to amisulpride. A case example].
Topics: Acute Disease; Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Pharyngeal Diseases; Psychotic Disorders; Receptors, Dopamine; Spasm; Sulpiride; Tongue Diseases | 2000 |
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
Topics: Amisulpride; Animals; Antipsychotic Agents; Clozapine; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Neostriatum; Nerve Degeneration; Neural Pathways; Neurons; Rats; Rats, Sprague-Dawley; Risperidone; Substance Withdrawal Syndrome; Substantia Nigra; Sulpiride | 2002 |
Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Female; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Risperidone; Schizophrenia; Sulpiride | 2002 |
Discriminative stimulus properties in rats of the novel antipsychotic quetiapine.
Topics: Amisulpride; Analysis of Variance; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Dibenzothiazepines; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Generalization, Psychological; Haloperidol; Loxapine; Quetiapine Fumarate; Quinoxalines; Rats; Rats, Wistar; Risperidone; Sulpiride | 2002 |
How does the benzamide antipsychotic amisulpride get into the brain?--An in vitro approach comparing amisulpride with clozapine.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzamides; Brain; Caco-2 Cells; Clozapine; Dose-Response Relationship, Drug; Humans; Sulpiride; Swine | 2003 |
A successful antipsychotic combination trial. Quo Vadis?
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Drug Therapy, Combination; Humans; Psychotic Disorders; Sulpiride | 2004 |
Effectiveness of amisulpride augmentation of clozapine in a non-responder to either drug alone: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Schizophrenia; Sulpiride | 2005 |
Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Male; Schizophrenia, Paranoid; Sialorrhea; Sulpiride | 2005 |
Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Drug Therapy, Combination; Humans; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2005 |
Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Satisfaction; Schizophrenia; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2004 |
Atypical anti-psychotics in the real world--a naturalistic comparative outcome study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Olanzapine; Patient Compliance; Probability; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Quetiapine Fumarate; Risk Assessment; Risperidone; Severity of Illness Index; Statistics, Nonparametric; Sulpiride; Treatment Outcome | 2005 |
[Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride].
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Commitment of Mentally Ill; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Haloperidol; Homicide; Humans; Insanity Defense; Male; Olanzapine; Prisoners; Schizophrenia, Paranoid; Sulpiride; Treatment Outcome | 2006 |
Alterations of glucose metabolism during treatment with clozapine or amisulpride: results from a prospective 16-week study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Body Mass Index; Clozapine; Female; Glucose; Glucose Metabolism Disorders; Homeostasis; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Prospective Studies; Risk Factors; Schizophrenia; Sulpiride | 2007 |
Remission and relapse in the outpatient care of schizophrenia: three-year results from the Schizophrenia Outpatient Health Outcomes study.
Topics: Adult; Ambulatory Care; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cohort Studies; Dibenzothiazepines; Europe; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Olanzapine; Prospective Studies; Quetiapine Fumarate; Recurrence; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Time Factors; Treatment Outcome | 2006 |
The use of atypical antipsychotics in French psychiatric hospitals.
Topics: Adult; Age Factors; Amisulpride; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; France; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Middle Aged; Olanzapine; Practice Patterns, Physicians'; Psychotic Disorders; Risperidone; Sex Factors; Sulpiride | 2007 |
Clozapine and amisulpride in refractory schizophrenia and alcohol dependence.
Topics: Alcoholism; Amisulpride; Antipsychotic Agents; Behavior, Addictive; Blood Glucose; Clozapine; Comorbidity; Diabetes Mellitus; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Humans; Male; Middle Aged; Schizophrenia; Sulpiride | 2007 |
Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Dibenzothiazepines; Humans; Male; Middle Aged; Myocarditis; Quetiapine Fumarate; Schizophrenia; Sulpiride | 2008 |
Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Male; Medical Records; Middle Aged; Olanzapine; Patient Admission; Polypharmacy; Practice Patterns, Physicians'; Quetiapine Fumarate; Research Design; Retrospective Studies; Risperidone; Schizophrenia; Scotland; Sulpiride | 2008 |
Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15.
Topics: Amisulpride; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Biological Availability; Catalepsy; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Male; Motor Activity; Olanzapine; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D3; Sulfonamides; Sulpiride; Tissue Distribution | 2008 |
Amisulpride the 'atypical' atypical antipsychotic--comparison to haloperidol, risperidone and clozapine.
Topics: Amisulpride; Amphetamine; Animals; Antipsychotic Agents; Basal Ganglia; Behavior, Animal; Blood-Brain Barrier; Brain; Clozapine; Conditioning, Psychological; Haloperidol; Male; Models, Animal; Motor Activity; Phencyclidine; Prefrontal Cortex; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Serotonin; Risperidone; Sulpiride | 2008 |
Antipsychotics possessing antidepressive efficacy increase Golf protein in rat striatum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Benzodiazepines; Blotting, Western; Clozapine; Corpus Striatum; Depressive Disorder; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits; Haloperidol; Injections, Intraperitoneal; Male; Olanzapine; Rats; Rats, Wistar; Risperidone; Sulpiride; Time Factors | 2008 |
Tardive dystonia associated with low-dose of amisulpride: a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Schizophrenia, Paranoid; Sulpiride | 2008 |
Amisulpride treatment for clozapine-induced sialorrhea.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Humans; Male; Receptors, Dopamine D3; Schizophrenia, Paranoid; Sialorrhea; Sulpiride | 2009 |
Tardive dystonia induced by switch of atypical antipsychotics.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Olanzapine; Schizophrenia; Sulpiride | 2010 |
Amisulpride for clozapine induced sialorrhea.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Female; Humans; Sialorrhea; Sulpiride | 2009 |
Relief from chronic intractable auditory hallucinations after long-term bilateral theta burst stimulation.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Cognitive Behavioral Therapy; Combined Modality Therapy; Dominance, Cerebral; Follow-Up Studies; Hallucinations; Humans; Middle Aged; Parietal Lobe; Schizophrenia, Paranoid; Sulpiride; Temporal Lobe; Theta Rhythm; Transcranial Magnetic Stimulation; Treatment Outcome | 2010 |
Clock genes and body composition in patients with schizophrenia under treatment with antipsychotic drugs.
Topics: Adult; Age Factors; Alleles; Amisulpride; Anthropometry; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Composition; Body Mass Index; CLOCK Proteins; Clozapine; Dibenzothiazepines; Drug Therapy, Combination; Female; Genetic Association Studies; Genetic Carrier Screening; Genotype; Humans; Long-Term Care; Male; Middle Aged; Mutation, Missense; Olanzapine; Period Circadian Proteins; Piperazines; Polymorphism, Single Nucleotide; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptor, Melanocortin, Type 3; Receptors, Glucocorticoid; Receptors, Leptin; Risperidone; Schizophrenia; Sex Factors; Sulpiride; Syndecan-3 | 2011 |
Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Germany; Humans; Male; Matched-Pair Analysis; Obsessive-Compulsive Disorder; Olanzapine; Piperazines; Prevalence; Quinolones; Schizophrenia; Serotonin Antagonists; Severity of Illness Index; Sulpiride | 2011 |
Clozapine-induced salivation: interaction with N-desmethylclozapine and amisulpride in an experimental rat model.
Topics: Abdomen; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amisulpride; Animals; Antipsychotic Agents; Blood Pressure; Chorda Tympani Nerve; Clozapine; Female; Lingual Nerve; Liver Circulation; Methacholine Chloride; Models, Animal; Muscarinic Agonists; Parasympathectomy; Phentolamine; Propranolol; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Saliva; Salivation; Submandibular Gland; Sulpiride; Time Factors | 2011 |
Amisulpride augmentation of clozapine in refractory schizophrenia.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Humans; Male; Middle Aged; Schizophrenia; Sulpiride | 2011 |
Effects of amisulpride and aripiprazole on progressive-ratio schedule performance: comparison with clozapine and haloperidol.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Clozapine; Conditioning, Operant; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Kinetics; Models, Biological; Motor Activity; Motor Skills; Piperazines; Quinolones; Rats; Rats, Wistar; Reaction Time; Reinforcement Schedule; Serotonin Antagonists; Sulpiride | 2012 |
Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Case-Control Studies; Clozapine; Cohort Studies; Dibenzothiazepines; Dibenzothiepins; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Olanzapine; Pneumonia; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Sulpiride; Taiwan | 2013 |
Atypical antipsychotics--effects of amisulpride on salivary secretion and on clozapine-induced sialorrhea.
Topics: Amisulpride; Amylases; Animals; Antipsychotic Agents; Autonomic Agents; Bethanechol; Clozapine; Denervation; Female; Isoproterenol; Methacholine Chloride; Parasympathetic Nervous System; Parotid Gland; Raclopride; Rats; Rats, Sprague-Dawley; Saliva; Salivation; Sialorrhea; Submandibular Gland; Substance P; Sulpiride; Sympathetic Nervous System | 2012 |
Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amisulpride; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Female; Humans; Linear Models; Male; Middle Aged; Smoking; Sulpiride; Young Adult | 2012 |
Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study).
Topics: Adult; Amisulpride; Antioxidants; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Catalase; Clozapine; Dibenzothiazepines; Enzyme Activation; Erythrocytes; Glutathione Peroxidase; Glutathione Reductase; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Sulpiride; Superoxide Dismutase; Superoxide Dismutase-1; Thiazoles; Treatment Outcome; Young Adult | 2013 |
LC-MS/MS of some atypical antipsychotics in human plasma, serum, oral fluid and haemolysed whole blood.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Stability of some atypical antipsychotics in human plasma, haemolysed whole blood, oral fluid, human serum and calf serum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cattle; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Drug Stability; Female; Forensic Toxicology; Hemolysis; Humans; Isoxazoles; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Pyrimidines; Quetiapine Fumarate; Quinolones; Reproducibility of Results; Risperidone; Saliva; Serum; Sulpiride; Tandem Mass Spectrometry | 2013 |
Clozapine augmented with amisulpride in 3 cases of treatment-resistant early- and very early-onset schizophrenia.
Topics: Adolescent; Amisulpride; Antipsychotic Agents; Clozapine; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Schizophrenia, Childhood; Schizophrenic Psychology; Sulpiride; Treatment Outcome | 2013 |
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Female; Humans; Hypochondriasis; Male; Middle Aged; Obsessive-Compulsive Disorder; Olanzapine; Paliperidone Palmitate; Prevalence; Quetiapine Fumarate; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2014 |
Augmentation of clozapine with amisulpride: an effective therapeutic strategy for violent treatment-resistant schizophrenia patients in a UK high-security hospital.
Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Blood Glucose; Body Mass Index; Cholesterol; Cholesterol, HDL; Clozapine; Cohort Studies; Drug Therapy, Combination; Hospitals, Psychiatric; Humans; Male; Retrospective Studies; Schizophrenia; Schizophrenic Psychology; Security Measures; Sulpiride; Treatment Outcome; United Kingdom; Violence; Young Adult | 2014 |
Increased orbitofrontal cortex activation associated with "pro-obsessive" antipsychotic treatment in patients with schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain Mapping; Clozapine; Executive Function; Female; Humans; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Obsessive Behavior; Olanzapine; Piperazines; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Quinolones; Schizophrenia; Sulpiride | 2015 |
Clozapine augmentation with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Synergism; Humans; Male; Schizophrenia; Sulpiride | 2014 |
Skating on thin ice: pragmatic prescribing for medication refractory schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Prescriptions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Valproic Acid | 2015 |
Severe acute pancreatitis, neuroleptic malignant syndrome and grand mal seizures associated with elevated amisulpride and low clozapine serum levels.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Pancreatitis; Schizophrenia; Seizures | 2015 |
Adjunctive ondansetron in schizophrenia--A pilot study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Feasibility Studies; Humans; Ondansetron; Pilot Projects; Schizophrenia; Sulpiride; Treatment Outcome | 2016 |
Antipsychotic Drugs Differentially Affect mRNA Expression of Genes Encoding the Neuregulin 1-Downstream ErbB4-PI3K Pathway.
Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Cell Line, Tumor; Cell Survival; Clozapine; Gene Expression Regulation; Haloperidol; Humans; Neuregulin-1; Olanzapine; Phosphatidylinositol 3-Kinases; Quetiapine Fumarate; Receptor, ErbB-4; RNA, Messenger; Schizophrenia; Sulpiride | 2016 |
Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Cognition; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Psychotic Disorders; Risperidone; Schizophrenia; Sulpiride; Thioredoxins; Young Adult | 2017 |
Measurement of Clozapine, Norclozapine, and Amisulpride in Plasma and in Oral Fluid Obtained Using 2 Different Sampling Systems.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Body Fluids; Chromatography, Liquid; Clozapine; Drug Monitoring; Female; Humans; Male; Middle Aged; Mouth; Plasma; Sulpiride; Tandem Mass Spectrometry; Young Adult | 2017 |
Rapid remission of first-episode schizophrenia with standardised treatment.
Topics: Amisulpride; Clozapine; Humans; Olanzapine; Psychotic Disorders; Schizophrenia | 2018 |
Antipsychotic treatments: who is really failing here? - Authors' reply.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Olanzapine; Psychotic Disorders; Schizophrenia | 2018 |
Antipsychotic treatments: who is really failing here?
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Humans; Olanzapine; Psychotic Disorders; Schizophrenia | 2018 |
Discriminative stimulus properties of the typical antipsychotic haloperidol compared to other antipsychotic drugs in C57BL/6 mice.
Topics: Amisulpride; Animals; Antipsychotic Agents; Aripiprazole; Clozapine; Discrimination Learning; Discrimination, Psychological; Dose-Response Relationship, Drug; Haloperidol; Male; Mice; Mice, Inbred C57BL | 2019 |
[Amisulpride, a one-of-a-kind and highly efficacious antipsychotic agent in the treatment of first-episode psychosis].
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Drug Monitoring; Drug Substitution; Humans; Olanzapine; Patient Selection; Psychotic Disorders; Schizophrenia | 2019 |
Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride).
Topics: Agranulocytosis; Amisulpride; Antipsychotic Agents; Clozapine; Granulocyte Colony-Stimulating Factor; Humans; Male; Middle Aged; Schizophrenia | 2020 |
Identification and Quantification of Antipsychotics in Blood Samples by LC-MS-MS: Case Reports and Data from Three Years of Routine Analysis.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chromatography, Liquid; Clozapine; Dibenzothiazepines; Female; Forensic Toxicology; Humans; Male; Olanzapine; Paliperidone Palmitate; Piperazines; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia; Substance Abuse Detection; Suicide; Sulpiride; Tandem Mass Spectrometry; Thiazoles | 2020 |
Characteristics of adverse reactions among antipsychotic drugs using the Korean Adverse Event Reporting System database from 2010 to 2019.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Clozapine; Drug-Related Side Effects and Adverse Reactions; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Retrospective Studies; Risperidone; Schizophrenia | 2022 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Creatine Kinase; Drug Monitoring; Hormones; Humans; Isoenzymes; Lipids; Schizophrenia | 2022 |